The Commission for the Protection of Competition received a notification of a proposed concentration, concerning the acquisition of the share capital of TP Group-CI Inc. by EQT Mid Market US Limited Partnership, via Bambino Midco Inc..
EQT Mid Μarket US Limited Partnership is a global investment firm which offers a wide range of alternative investment funds and other investment products to investors. The company also provides capital market solutions. Private equity funds managed by EQT invests in companies in various sectors.
Bambino Midco Inc. is indirectly controlled by the EQT Mid Market US Limited Partnership and is a vehicle company for the purposes of this acquisition.
TP Group-CI Inc, is a company duly registered under the laws of United States of America. This company, together with its subsidiaries (hereinafter "Clinical Innovations"), manufactures and distributes mainly disposable products for the childbirth unit and for the neonatal intensive care unit, i.e. medical care products for women after birth and for newborns. Clinical Innovations products include the Koala® Intrauterine Pressure Catheter and the Kiwi® Vacuum-Assisted Delivery System